Therapeutic vaccine platform to boost immune responses in tuberculosis
Active Definitive Contract Awarded Last action
- Contract number
- 75N93025C00024
- Awardee
-
L2 Diagnostics LLC UEI GKA7VH5LFR25
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,471
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · SBIR20251 · Posted Jul 18, 2024
- Contract value 100% obligated
- $599,471.00 Current and potential, with all options
- Completion date 63% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Woodbridge, CT 06525, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $599,471 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $599,471 definitive contract to L2 Diagnostics LLC for development of a therapeutic vaccine platform to boost immune responses in tuberculosis on August 1, 2025, under a total small business set-aside.
The award derives from the Small Business Innovation Research (SBIR) program solicitation posted July 18, 2024, with an October 18, 2024 due date. L2 Diagnostics LLC is a small business specializing in biomedical research and vaccine development for infectious diseases. Place of performance is Woodbridge, Connecticut. The contract runs through July 31, 2027 on a firm fixed-price basis.
Quick answers
Who was awarded contract 75N93025C00024?
75N93025C00024 was awarded to L2 Diagnostics LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2025.
How much is contract 75N93025C00024 worth?
The government has obligated $599,471 on 75N93025C00024.
Was contract 75N93025C00024 competed?
The extent of competition for 75N93025C00024 was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award